| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 159,848 | 156,549 | 130,453 | 116,350 | | Cost of Revenue | 150,101 | 144,607 | 120,945 | 106,922 | | | Gross Profit | 9,747 | 11,942 | 9,508 | 9,428 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,697 | 7,402 | 7,258 | 6,317 | | Non Recurring | (133) | 133 |
-
|
-
| | Others | 662 | 659 | 638 | 1,002 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,521 | 3,748 | 1,612 | 2,109 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,521 | 3,748 | 1,612 | 2,109 | | Interest Expense | 28 | 56 | 64 | 97 | | Income Before Tax | 1,493 | 3,692 | 1,548 | 2,012 | | Income Tax Expense | 649 | 1,579 | 663 | 968 | | Minority Interest | (324) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 520 | 2,113 | 885 | 1,044 | | | Non-recurring Events | | Discontinued Operations | 196 | (10) | (186) | 109 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 716 | 2,103 | 699 | 1,153 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $716 | $2,103 | $699 | $1,153 |
|
0.02% Nasdaq 
Income Statement
